Overview: Red Cell Distribution Width TestIntroduction: The Red Cell Distribution Width Test measures RDW to diagnose anemia types, causing weakness or pallor. Aligned with 2023 ASH guidelines, it uses hematological methods for high specificity, supporting blood disorder screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in hematology for patients with suspected anemia.
Other Names: RDW Assay, Erythrocyte Size Variation Test.
FDA Status: Laboratory-developed test (LDT), meeting hematology standards for diagnostic accuracy.
Historical Milestone: RDW testing began in the 1980s with automated hematology analyzers. Methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures RDW to diagnose anemia types, guides treatment, and evaluates patients with weakness or pallor.
Test Parameters: 1. Red Cell Distribution Width
Pretest Condition: No fasting required. Collect whole blood. Report history of weakness, pallor, or anemia symptoms.
Specimen: Whole Blood (EDTA, 2-5 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document weakness, pallor, or family history of anemia. Include current medications, especially iron supplements.
Consent: Written consent required, detailing the tests purpose, anemia implications, and risks of sample collection.
Procedural Considerations: Uses automated hematology analyzers to measure RDW. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for anemia diagnosis.
Factors Affecting Result Accuracy: Improper sample storage or hemolysis can affect results. Bone marrow disorders may alter RDW.
Clinical Significance: Elevated RDW confirms anemia type, guiding iron, B12, or folate therapy. Normal RDW may require further blood tests.
Specialist Consultation: Consult a hematologist for result interpretation and treatment planning.
Additional Supporting Tests: Hemoglobin, MCV, or peripheral smear to confirm anemia diagnosis.
Test Limitations: Non-specific for certain anemia types; clinical correlation is needed. Sample quality affects sensitivity.
References: ASH Anemia Guidelines, 2023; Blood, Bessman JD, 2022.
